As a young plant scientist, Joanne Chory shook up the research establishment with her unconventional approach to figuring out how plants work. Her methods and success changed the field, and led her to her biggest project yet—tackling climate change, with the help of millions of plants. Colleagues Steve Kay, Detlef Weigel, and Jennifer Nemhauser describe what made Joanne outstanding in the field of plant scientists. Plus Joanne’s sister, Mary Ann Chory, describes their early family life and the sibling relationships that shaped them. Joanne Chory died in November 2024 at age 69 from complications due to Parkinson’s disease.“The Leap” is a 10-episode audio series that profiles scientists willing to take big risks to push the boundaries of discovery. It premieres on Science Friday’s podcast feed every Monday until July 21. “The Leap” is a production of the Hypothesis Fund, brought to you in partnership with Science Friday.Transcript is available on sciencefriday.com.
Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
Talk
Science Friday Folgen
Covering the outer reaches of space to the tiniest microbes in our bodies, Science Friday is the source for entertaining and educational stories about science, technology, and other cool stuff.
Folgen von Science Friday
1191 Folgen
-
Folge vom 02.06.2025The Leap: Be Bold Or Just Don't Do It
-
Folge vom 30.05.2025What Huge Cuts To NSF Funding Mean For ScienceGrant funding by the National Science Foundation has been cut by more than half this year, bringing the foundation’s science funding to its lowest level in decades. Katrina Miller, who covers science for the New York Times, joins Host Flora Lichtman to unpack the cutbacks and discuss where the funding changes might lead.And, the FDA has cleared a blood test to help diagnose Alzheimer’s disease. The first-of-its-kind test measures the levels of amyloid and tau proteins in a patient’s blood, two major biomarkers of the disease. Alzheimer’s researcher Jason Karlawish joins Flora to explain this new diagnostic tool and what it means for patients.Guests:Katrina Miller is a science reporter for The New York Times based in Chicago.Dr. Jason Karlawish is a professor of medicine, medical ethics and health policy, and neurology at the University of Pennsylvania’s Perelman School of Medicine, and co-director of the Penn Memory Center, based in Philadelphia, Pennsylvania.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
-
Folge vom 29.05.2025What Happens When Air Traffic Control Systems Go Dark?At the end of April, air traffic control radar surveillance and radio communication systems at Newark Liberty International Airport went dark for over a minute. A week and half later, radar went down again briefly. The Federal Aviation Administration (FAA) has since cut down the number of flights in and out of Newark. But, how does our air traffic control system work? How do air traffic controllers keep track of all of the planes in the sky? And what happens when systems fail? Michael McCormick, a former air traffic control operations manager at the FAA, joins Host Flora Lichtman to dive into the science of air traffic control. Guest: Dr. Michael McCormick is a former vice president of the FAA’s Air Traffic Organization, and an associate professor and program coordinator of Air Traffic Management at Embry-Riddle Aeronautical University.Transcripts for the segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
-
Folge vom 28.05.2025Could The NIH Plan For A ‘Universal Vaccine’ Really Work?At the beginning of May, the National Institutes of Health, part of the Department of Health and Human Services, announced a plan to develop a universal vaccine platform. Think: a single shot for flu or COVID-19 that would last years, maybe a lifetime. The plan—called Generation Gold Standard—has a reported budget of $500 million, and a tight deadline. But will it work? And where does the science on this actually stand? In this live broadcast, Hosts Flora Lichtman and Ira Flatow talk with epidemiologist Michael Osterholm and vaccine researcher Ted Ross.Guests: Michael Osterholm is Director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota in Minneapolis, Minnesota.Dr. Ted Ross is the global director of vaccine research at the Cleveland Clinic’s Florida Research and Innovation Center in Port St. Lucie, Florida. Transcript will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.